Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Assembly Biosciences (ASMB) Change in Cash: 2015-2025

Historic Change in Cash for Assembly Biosciences (ASMB) over the last 11 years, with Sep 2025 value amounting to -$1.5 million.

  • Assembly Biosciences' Change in Cash fell 115.92% to -$1.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$5.9 million, marking a year-over-year decrease of 429.51%. This contributed to the annual value of $18.5 million for FY2024, which is 156.80% up from last year.
  • Per Assembly Biosciences' latest filing, its Change in Cash stood at -$1.5 million for Q3 2025, which was down 348.23% from $593,000 recorded in Q2 2025.
  • Assembly Biosciences' Change in Cash's 5-year high stood at $18.8 million during Q1 2021, with a 5-year trough of -$25.1 million in Q4 2021.
  • Moreover, its 3-year median value for Change in Cash was -$1.1 million (2024), whereas its average is -$2.7 million.
  • Within the past 5 years, the most significant YoY rise in Assembly Biosciences' Change in Cash was 526.90% (2021), while the steepest drop was 2,318.27% (2021).
  • Assembly Biosciences' Change in Cash (Quarterly) stood at -$25.1 million in 2021, then surged by 91.03% to -$2.3 million in 2022, then tumbled by 202.22% to -$6.8 million in 2023, then soared by 245.15% to $9.9 million in 2024, then slumped by 115.92% to -$1.5 million in 2025.
  • Its Change in Cash stands at -$1.5 million for Q3 2025, versus $593,000 for Q2 2025 and -$14.9 million for Q1 2025.